ArticleHuman vaccines & immunotherapeutics2025

Participant motivators and perceptions of risks and benefits in adult Phase 2/3 COVID-19 vaccine clinical trials.

Bettina Wunderlich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.